Co-Diagnostics - 7 Year Stock Price History | CODX
Historical daily share price chart and data for Co-Diagnostics since 2017 adjusted for splits and dividends. The latest closing stock price for Co-Diagnostics as of December 17, 2024 is 0.76.
- The all-time high Co-Diagnostics stock closing price was 30.80 on August 03, 2020.
- The Co-Diagnostics 52-week high stock price is 2.23, which is 193.4% above the current share price.
- The Co-Diagnostics 52-week low stock price is 0.73, which is 3.9% below the current share price.
- The average Co-Diagnostics stock price for the last 52 weeks is 1.21.
| Co-Diagnostics Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2024 | 1.2044 | 1.4200 | 1.7500 | 0.7600 | 0.7600 | -42.86% |
| 2023 | 1.5923 | 2.5300 | 3.2400 | 1.0000 | 1.3300 | -47.22% |
| 2022 | 4.9293 | 9.3100 | 9.6100 | 2.3200 | 2.5200 | -71.78% |
| 2021 | 10.0542 | 9.9700 | 19.2100 | 7.1600 | 8.9300 | -3.98% |
| 2020 | 12.6610 | 0.9103 | 30.8000 | 0.9103 | 9.3000 | 938.87% |
| 2019 | 1.0546 | 1.5500 | 2.2400 | 0.7120 | 0.8952 | -39.92% |
| 2018 | 2.6845 | 2.7600 | 5.2800 | 1.1500 | 1.4900 | -43.56% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.027B | $0.007B |
| Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $88.458B | 10.98 |
| Cencora (COR) | United States | $44.887B | 16.88 |
| DiDi Global (DIDIY) | China | $22.698B | 0.00 |
| Natera (NTRA) | United States | $21.988B | 0.00 |
| ICON (ICLR) | Ireland | $17.171B | 15.29 |
| Avantor (AVTR) | United States | $15.198B | 22.79 |
| Viatris (VTRS) | United States | $15.075B | 4.64 |
| Revvity (RVTY) | United States | $14.110B | 24.51 |
| BioMerieux (BMXMF) | France | $12.668B | 0.00 |
| CochLear (CHEOY) | Australia | $12.105B | 0.00 |
| Solventum (SOLV) | United States | $12.017B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.752B | 30.29 |
| Charles River Laboratories (CRL) | United States | $9.739B | 18.82 |
| Doximity (DOCS) | United States | $9.734B | 57.30 |
| Sonic Healthcare (SKHHY) | Australia | $8.494B | 0.00 |
| HealthEquity (HQY) | United States | $8.287B | 41.57 |
| Bausch + Lomb (BLCO) | Canada | $6.550B | 30.49 |
| Organon (OGN) | United States | $3.940B | 3.97 |
| Sotera Health (SHC) | United States | $3.725B | 19.92 |
| BrightSpring Health Services (BTSG) | United States | $3.232B | 68.74 |
| Concentras Parent (CON) | United States | $2.611B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.588B | 29.51 |
| Ardent Health Partners (ARDT) | United States | $2.382B | 0.00 |
| PACS (PACS) | United States | $2.348B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.195B | 0.00 |
| Premier (PINC) | United States | $2.094B | 10.90 |
| GeneDx Holdings (WGS) | United States | $2.072B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.795B | 47.10 |
| Teladoc Health (TDOC) | United States | $1.794B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.731B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.288B | 0.00 | |
| Progyny (PGNY) | United States | $1.244B | 25.19 |
| CareDx (CDNA) | United States | $1.226B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.208B | 11.82 |
| Embecta (EMBC) | United States | $1.134B | 7.93 |
| AMN Healthcare Services Inc (AMN) | United States | $1.029B | 6.96 |
| Agilon Health (AGL) | United States | $0.923B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| InnovAge Holding (INNV) | United States | $0.601B | 0.00 |
| SBC Medicals (SBC) | United States | $0.596B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.481B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.474B | 0.00 |
| DocGo (DCGO) | United States | $0.438B | 16.50 |
| Enhabit (EHAB) | United States | $0.428B | 37.04 |
| Sera Prognostics (SERA) | United States | $0.291B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.289B | 0.00 |
| ModivCare (MODV) | United States | $0.255B | 13.81 |
| LifeMD (LFMD) | United States | $0.246B | 0.00 |
| Beauty Health (SKIN) | United States | $0.196B | 0.00 |
| Biodesix (BDSX) | United States | $0.195B | 0.00 |
| Nutex Health (NUTX) | United States | $0.190B | 0.00 |
| MultiPlan (MPLN) | United States | $0.117B | 0.00 |
| So-Young (SY) | China | $0.094B | 16.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.088B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
| NeueHealth (NEUE) | United States | $0.043B | 1.13 |
| OncoCyte (OCX) | United States | $0.039B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.026B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.023B | 0.00 |
| Oncology Institute (TOI) | United States | $0.017B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| KindlyMD (KDLY) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |
| Aclarion (ACON) | United States | $0.001B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.000B | 0.00 |